Disentangling and Treating ADHD and Anxiety
|
|
- Philippa Lawrence
- 5 years ago
- Views:
Transcription
1 Disentangling and Treating ADHD and Anxiety Oscar Bukstein, MD Andrew Potash, PsyD 1 Disclosures of Potential Conflicts Source Research Funding Advisor/ consultant Employee Speaker s Bureau Books, Intellectual Property In-kind services Stock or Equity Honorarium or expenses for this meeting Routlege Press x Wolters Kluwer Health X 1
2 Prevalence ADHD DSM-V 5% of children, 2.5% of adults (APA DSM-V, 2013) Other sources 2011: U.S. children currently diagnosed according to parent report 8.8%. Ever diagnosed 11% (CDC, 2018) 4.4% of adults (Kessler et al., 2006) Anxiety disorders 33.7% lifetime rate, 21.3% annual rate for U.S. population (Kessler et al., 2012) 3 Comorbidity Percentage of children with ADHD and another disorder 4 (CDC Website, 2018) 2
3 Overlapping Symptoms ADHD LD ASD PTSD ODD/CD Anxiety Depression Personality Disorders ADHD -vs- Anxiety Inattention -vs- Preoccupation Hyperactivity -vs- Hyperarousal Impulsivity -vs- Escape/Avoidant Behavior 6 3
4 Anxiety posing as ADHD 7 Unfocused Reactive Talkative Fidgety Pressured On Edge Dependent on Accommodations Avoidant Preoccupied Restless Keyed-up Nervous Arousal Worried Attention-Seeking Fatigued at End of School Day Impatient ADHD -vs- Anxiety Neurodevelopmental -vs- State-based 8 4
5 ADHD + Anxiety =? Response inhibition (physiological anxiety) Sustained attention More inattentive than impulsive Working memory Auditory emotion recognition Response inhibition (cognitive anxiety) (Jarrett et al., 2016) 9 Impact on Overall Functional Impairment ADHD+Anxiety Increases: Overall impairment Symptom severity Attentional problems School fears Sluggish Cognitive Tempo (i.e., reduces tempo) Decreases Overall attentional, cognitive, and executive functioning Impulsivity Social competence ( Rejection Sensitive Dysphoria ) Anxiety has a greater negative impact on working memory than does ADHD. Presence of 2 or more anxiety disorders leads to poorer outcomes and greater functional impairment. (Brown et al., 2008; Greene et al., 2001; Karustis et al., 2000; Manassis et al., 2007; Newcorn et al., 2001; Newcorn et al., 2004Pliska, 1992; Tannock et al., 1995; Sciberras et al., 2014) 5
6 ADHD leading to anxiety 11 Persistence of ADHD into adulthood is associated with generalized anxiety disorder (OR, 5.19). 12 6
7 Anxiety Behavior Inhibition ADHD vs Anxiety ADHD Behavior Disinhibition Both systems share Frontal connectivity Through different subcortical networks Frontal cortex amygdala Anterior cingulate: cognitive/emotional responses striatum 13 Assessment Measures Anxiety Screen for Child Anxiety Related Disorders (SCARED) Multi-dimensional Anxiety Scale for Children (MASC) ADHD Vanderbilt Connors IOWA Connors SNAP IV ADRS - adult CAARS - adult Global scales with anxiety/adhd subscales Child Behavior Checklist (CBCL) Behavioral Assessment System for Children (BASC) Conners Comprehensive Behavior System (CBRS) 7
8 Assessment Diagnostic Interview history and chronology ADHD Rating scales children: parent, teacher Adults: self and significant other Anxiety Rating Scales - self-report, (parents for children) Which to Treat First?? The disorder that has the greatest effect on current functioning/causes more impairment Children: Usually ADHD Exception: extreme avoidance (school refusal) Adults: Usually Anxiety Depends on severity, impairment, avoidance 8
9 Does Successful Treatment of ADHD Improve Anxiety Symptoms? Direct or Indirect Effects Abikoff et al 2005 Coughlin et al., 2015 Meta-analysis Risk of anxiety decreased with stimulants (vs placebo) both low and high dose stimulants Likely indirect effects Other Studies Kendall et al., 2001: remission of primary ANX predicted remission of comorbidity Lack of control of medication status Control of ADHD Symptoms? 9
10 Children: ADHD as Initial Treatment Hyperactivity/Impulsivity/comorbidity with CD/ODD Parents/teachers, not children, decide on referral to Tx Anxiety has not progressed enough Exceptions: high level of avoidance ( school refusal ; Selective Mutism) Adults: Anxiety D/O as Initial Treatment Adults get to decide on (self-) referral Comorbidity with mood disorders Progression and impairments of Anxiety Disorder(s) in adulthood Difficulty in ascertaining improvement in ADHD sx if anxiety/(mood) unimproved 10
11 Do Children with ADHD + Anxiety Respond as well to Stimulants? Studies from early 90 s suggest that MPH not as effective in those with Anxiety D/Os (Buitelaar et al., 1995; Ter-Stepanian et al., 2010) Multi-modal Treatment Study of ADHD (MTA): no difference +/- stimulant response Improved response to behavioral treatment (Combination TX) in those with anxiety (Jensen et al., 2001) Children: Treatment Plan 1. Control ADHD sx and associated problems (including DBDs) A. Stimulants (MPH/AMP)/non-stimulants as needed B. PMT/school resources 2. Re-evaluate ANX sx 3. Control ANX sx and associated problems (including mood disorders) A. Augmented CBT for ANX (consider family-based B. SSRIs 11
12 Adult Treatment Plan 1. Control ANX sx and associated problems (including mood disorders) A. CBT for ANX B. SSRIs 2. Evaluate ANX symptoms 3. Control ADHD sx A. Stimulants (MPH/AMP)/non-stimulants as needed B. (CBT for ADHD) Medications for ADHD-ANX D/O Stimulants, alpha-agonists, and atomoxetine improve ADHD (AHRQ, 2018) Stimulant medication may increase the effectiveness of CBT (Hinshaw, Henker, & Whalen, 1984) 12
13 Anxiety Side Effects of Stimulant Medication Anxiety and nervousness common side effects Abdominal pain, anorexia, constipation, dizziness, dry mouth, headache, insomnia, jitteriness, irritability, nausea, and palpitations (Greenhill, 2001) Jitteriness and social withdrawal (AAP, 2001) Anxiety in Children Treated with Stimulants Risk of anxiety STIM<Pl (RR=0.86) Higher doses of STIM associated with reduced risk of anxiety vs PL (p=0.019) 13
14 Treatment Issues for Anxiety CBT requires habituation (exposure) Inattention/distractibility/over activity may interfere with exposure Psychoeducation, participant modeling, cognitive restructuring Cognitive interventions largely ineffective for ADHD Other ADHD Comorbidities: CD, ODD 27 Explanations for Improved Anxiety with Stimulants 1. Stimulants have a direct effect in reducing anxiety no evidence 2. Stimulants indirectly reduce anxiety by improving ADHD symptoms Reduction in anxiogenic situations Fewer academic problems Reduced peer, parent conflict ADHD + SAD/GAD anxiety with STIM RX (Golubchik et al., 2014) ADHD + ANX D/O anxiety w/ STIM > Anx RX (Abikoff et al., 2005) 14
15 Selection of ADHD Medication Stimulants still #1; prefer long-acting MPH before AMP? 2 nd line: Atomoxetine (especially for adults) Alpha agonists Start low, go slow Atomoxetine- Adults Social anxiety disorder Adler et al (2010) Adler et al (2009) Donnelly et al (2009) Ravindran et a(2009) ATX significantly better than PBO Response rate better in ADHD (51%) than ADHD plus SAD (42%) CAARS:Inv:SV score improvement better in ADHD than ADHD + SAD ATX significantly improved ADHD symptoms (CAARS:Inv:SV) and anxiety scores (LSAS; CGI-OS; STAI), and quality of life (AAQoL) compared to PBO in Pts with ADHD and SAD. SAS was markedly improved ATX-mediated improvements in ADHD directly correlated with anxiety improvement in Pts with ADHD and SAD ATX not different from PBO in Pts with GSAD and without ADHD (LSAS) 15
16 Kratochvil et al (2005) Atomoxetine - Children RCT 7 17 years ATX plus PBO not significantly different from ATX and fluoxetine. Significant improvements in ADHD symptoms (ADHD-RS) and anxiety symptoms (MASC) Geller et al (2007) RCT 8 17 years ATX significantly improved ADHD symptoms (ADHD- RS) and anxiety (PARS) * ATX did not exacerbate comorbid anxiety Alpha Agonists for Anxiety Guanfacine XR vs PL for Primary ANX D/O in children safe but outcome ns except CGI-I (Strawn et al., 2017) Clonidine for panic, GAD in adults decrease anxiety symptoms; 17% worse (Hoehn-Saric et al. 1981) 16
17 Effect of ADHD on Anxiety Treatment - CAMS CAMS (Child/Adoles Anxiety Multi-Modal Study) CBT only, Med-only, Combo CBT only group: poorer immediate Tx response/remission rate Need Rx or other psychosocial interventions (Halldorsdottir et al., 2014; 2015) Counseling Approaches: Behavioral Therapy Operant Conditioning Parent Management Training School-based behavioral strategies Exposure-based therapy for anxiety 34 17
18 Counseling Approaches: Cognitive Restructuring Often helpful for anxiety Alter thought processes around internal and external cues Misperception of risk Sometimes helpful for ADHD Alter distortions around symptoms, self-efficacy Misperception of time/ability 35 Counseling Approaches: Interpersonal/Social Belonging Targets sense of social effectiveness Indirectly addresses impulse control, attunement/engagement 36 18
19 Counseling Approaches: Physiological Calming Transfers control from sympathetic (fight/flight) to parasympathetic (rest/digest) nervous system modes Enhances effectiveness of prefrontal/executive controls while reducing power of limbic/emotional Increases awareness of physiological state and sense of self-control 37 Can build Counseling Approaches: Mindfulness Self-awareness Self-acceptance Ability to purposely direct attention Ability to sustain attention 38 19
20 Counseling considerations and potential problems Focusing on one diagnosis at the expense of another Behavioral parenting training can increase anxiety, emotional dysregulation, and relational stress School-based behavioral interventions can increase stigma Social skills training can lead to contagion or stigma 39 Counseling considerations and potential problems Many therapies assume intact executive functioning Inattention/distractibility/hyperactivity may interfere with exposure and habituation Other comorbidities (CD-ODD-ASD-LD) may all impact treatment Increasing reliance on structure and planning Must be developmentally- (not age-) appropriate Contraindicated for OCD Increasing insight may also increase sense of hopelessness 40 20
21 Clinical Recommendations for ADHD-ANX d/o Comorbidity for Children Adequate assessment Flexibility in administration of ANX CBT Increased structure Interactive tasks to facilitate engagement Creative in presenting information in multiple ways Adapting Parent Management Training (PMT)/Operant strategies Including problem-solving skills Role play/homework 21
23/06/2015. Absolutely none!!
Absolutely none!! Child and adolescent Mental Health can we help? Dr Tina Nicholson CCFP Family Practitioner and Medical Lead, Cochrane Clinical Lecturer Dept Family Med. U of C. Member of CanReach Faculty
More informationSubstance Abuse and Suicide. Oscar Bukstein, MD, MPH
Substance Abuse and Suicide Oscar Bukstein, MD, MPH Disclosures of Potential Conflicts Source Research Funding Advisor/ consultant Employee Speaker s Bureau Books, Intellectual Property In-kind services
More informationCOMORBIDITY PREVALENCE AND TREATMENT OUTCOME IN CHILDREN AND ADOLESCENTS WITH ADHD
COMORBIDITY PREVALENCE AND TREATMENT OUTCOME IN CHILDREN AND ADOLESCENTS WITH ADHD Tine Houmann Senior Consultant Child and Adolescent Mental Health Center, Mental Health Services Capital Region of Denmark
More information9/29/2011 TRENDS IN MENTAL DISORDERS. Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Autism Spectrum Disorders
Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Jason J. Washburn, Ph.D., ABPP Director, Center for Evidence-Based Practice TRENDS IN MENTAL DISORDERS Autism Spectrum
More informationTrends in Child & Adolescent Mental Health: What to look for and what to do about it.
Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Jason J. Washburn, Ph.D., ABPP Director, Center for Evidence-Based Practice TRENDS IN MENTAL DISORDERS 1 Autism Spectrum
More informationWhat are the most common signs of ADHD? And what are the most common medication interventions?
What are the most common signs of ADHD? And what are the most common medication interventions? Bennett Gertz, MD, FAAP Developmental Behavioral Pediatrician Children s Developmental Health Services Albertina
More informationThe Adolescent with ADHD: Managing Transition
The Adolescent with ADHD: Managing Transition Professor Philip Hazell University of Sydney and Rivendell Child, Adolescent and Family Mental Health Service Disclosure Statement: Philip Hazell Source Eli
More informationPractical care of the Child with ADHD Kristina Hingre MD
Practical care of the Child with ADHD Kristina Hingre MD Objectives Know the DSM 5 Criteria for diagnosis of ADHD Identify 4 Comorbidities of ADHD Be familiar with the common ADHD medications and Side
More informationRole of ADHD medication in children with autism spectrum disorder. Pieter Hoekstra University of Groningen, Netherlands
Role of ADHD medication in children with autism spectrum disorder Pieter Hoekstra University of Groningen, Netherlands Symptoms of ADHD are highly prevalent in children with ASD Two independent chart reviews
More informationChild & Adolescent Psychiatry (a brief overview)
Child & Adolescent Psychiatry (a brief overview) Lance Feldman, MD, FAPA, MBA, BSN Vice Chair Clinical Affairs, Department of Psychiatry Affiliate Clinical Assistant Professor, University of South Carolina
More informationTo Give or not to Give Medication: That is the Question
To Give or not to Give Medication: That is the Question Charmi Patel Rao, MD September 14, 2018 Introduction Board Certified Child & Adolescent Psychiatrist Clinical expertise in ECMH and Developmental
More informationSome difficulties experienced in ASD & ADHD
ADHD & ASD Nicola Ryan CAMHS Clinical Nurse Specialist and Child CBT Therapist Senior Lecturer in Mental Health Kingston University & St Georges University of London Private practice: www.nicolaryan.net
More informationDisclosures. Learning Objectives. Psychopharmacology of Pediatric Anxiety and Depression 5/4/2017
Psychopharmacology of Pediatric Anxiety and Depression Susan Sharp, DO Clinical Assistant Professor of Child and Adolescent Psychiatry Kansas University Medical Center The Children's Mercy Hospital, 2017
More informationAttention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D.
Attention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D. PREVALENCE & STATISTICS 6-8% of all children have ADHD (CDC Statistical Data) Age of onset: 7 years old (Prior DSM-IV) 12 years old (Current
More informationfor anxious and avoidant behaviors.
Summary of the Literature on the Treatment of Anxiety Disorders in Children and Adolescents Sucheta D. Connolly, M.D.* Non-OCD anxiety disorders in youth are common and disabling, with 12-month prevalence
More informationTRAUMA AND PTSD ASSESSMENT AND INTERVENTION. Brooks Keeshin, MD University of Utah
TRAUMA AND PTSD ASSESSMENT AND INTERVENTION Brooks Keeshin, MD University of Utah Disclosures I receive funding from SAMHSA and Utah Department of Health, Uppsala University and Hunter College. I receive
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Age as factor in selective mutism, 623 as factor in social phobia, 623 Agoraphobia, 593 600 described, 594 596 DSM-V changes related to,
More informationThe New DSM- 5: A Clinical Discussion Through A Developmental Lens. Marit E. Appeldoorn, MSW, LICSW
The New DSM- 5: A Clinical Discussion Through A Developmental Lens Marit E. Appeldoorn, MSW, LICSW 612-412- 1159 mappeldoornlicsw@gmail.com Introductions and My (Not- So- Bad) Dilemma What We Already Know
More informationAttention Deficit Hyperactivity Disorder in Children and Adults
Attention Deficit Hyperactivity Disorder in Children and Adults Steven R. Pliszka, MD Professor and Chair Department of Psychiatry The University of Texas Health Science Center at San Antonio Speaker Disclosure
More informationPediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline
Pediatric Primary Care Mental Health Specialist Certification Exam Detailed Content Outline Description of the Specialty The Pediatric Primary Care Mental Health Specialist (PMHS) builds upon the Advanced
More informationADHD Assessment and Treatment in Primary Care
ADHD Assessment and Treatment in Primary Care Matthew Tolliver, Ph.D., Assistant Professor, ETSU Pediatrics Dr. David Wood, Professor and Chair, ETSU Pediatrics ADHD in Teenagers We have no financial disclosures.
More information6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.
Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders
More informationPrevious Study Return to List Next Study
A service of the U.S. National Institutes of Health Trial record 1 of 1 for: 42603ATT3013 Previous Study Return to List Next Study A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS
More informationMolly Faulkner, PhD, CNP, LISW UNM, Dept of Psychiatry and Behavioral Sciences Div of Community Behavioral Health
Molly Faulkner, PhD, CNP, LISW UNM, Dept of Psychiatry and Behavioral Sciences Div of Community Behavioral Health What is anxiety? What causes anxiety? When is anxiety a problem? What is the size of the
More informationSEPARATION ANXIETY. Ana Figueroa, Cesar Soutullo, Yoshiro Ono & Kazuhiko Saito. ANXIETY DISORDERS Chapter F.2. Adapted by Julie Chilton
ANXIETY DISORDERS Chapter F.2 SEPARATION ANXIETY Ana Figueroa, Cesar Soutullo, DEPRESSION IN CHILDREN AND Yoshiro Ono & ADOLESCENTS Kazuhiko Saito Adapted by Julie Chilton The IACAPAP Textbook of Child
More informationWeek 2: Disorders of Childhood
Week 2: Disorders of Childhood What are neurodevelopmental disorders? A group of conditions with onset in the developmental period Disorders of the brain The disorders manifest early in development, often
More informationUpdate on the Treatment of ADHD 2019
Update on the Treatment of ADHD 2019 James H. Beard, Jr., M.D, FAAP Developmental-Behavioral Pediatrician Division of Developmental Pediatrics The Rights of ADHD The right diagnosis of ADHD and co morbidities
More information2/23/18. Age of Anxiety: Transforming Qualms into Calm. Disclosures. Objectives. I have nothing to disclose
Age of Anxiety: Transforming Qualms into Calm Rosa Kim, MD Assistant Professor and Attending Child Psychiatrist Medical College of Wisconsin and Children s Hospital of Wisconsin Disclosures I have nothing
More informationPharmacotherapy of ADHD with Non-Stimulants
Pharmacotherapy of ADHD with Non-Stimulants Timothy E. Wilens, M.D. Chief, Division of Child and Adolescent Psychiatry, (Co)Director of Center for Addiction Medicine, Massachusetts General Hospital Massachusetts
More informationDifferential Diagnosis. Differential Diagnosis 10/29/14. ASDs. Mental Health Disorders. What Else Could it Be? and
Differential Diagnosis ASDs and Mental Health Disorders - Matt Reese, PhD Differential Diagnosis What Else Could it Be? Differential Diagnosis: The process of distinguishing one disorder from others which
More informationObjectives. Co-Morbidity. Overview 4/19/16. Importance of Diagnosing Other Conditions. Difficulties with Dual Diagnosis. Caitlin Walsh, PhD 1
When it Isn t Just Autism: Co-Morbid Mental Health Conditions and ASD Caitlin Walsh, PhD Objectives 1. Report on prevalence of most common disorders that are co-morbid with ASD. 2. Identify difficulties
More informationDisclosures. Questions. A Developmental Approach. Goals and objectives 4/3/2018 FEARS AND TEARS: TREATING ANXIETY AND DEPRESSION IN PRIMARY CARE
Disclosures FEARS AND TEARS: TREATING ANXIETY AND DEPRESSION IN PRIMARY CARE I have no financial interests I WILL be talking about non FDA approved uses of medications for anxiety and depression in children
More informationIntelligent Prescribing. Optimizing Medication Treatments in ADHD Dr Dave Coghill
Intelligent Prescribing Optimizing Medication Treatments in ADHD Dr Dave Coghill Source Consultant Advisory Board Stock Equity >$10,000 Speaker Research Lilly X X X Janssen/ McNeil X X X UCB X X Shire
More informationPharmacotherapy of ADHD with Non- Stimulants
Pharmacotherapy of ADHD with Non- Stimulants Timothy E. Wilens, M.D. Chief, Division of Child and Adolescent Psychiatry, (Co)Director of Center for Addiction Medicine, Massachusetts General Hospital Massachusetts
More informationAttention deficit hyperactivity disorder (update)
National Institute for Health and Care Excellence Final Attention deficit hyperactivity disorder (update) [I]Withdrawal from pharmacological treatment and drug holidays NICE guideline NG87 Intervention
More informationHERTFORDSHIRE PARTNERSHIP UNIVERSITY NHS FOUNDATION TRUST. Referral Criteria for Specialist Tier 3 CAMHS
Referral Criteria for Specialist Tier 3 CAMHS Specialist CAMHS provides mental health support, advice and guidance and treatment for Children and Young People with moderate or severe mental health difficulties,
More informationSECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario
SECTION 1 Children and Adolescents with Depressive Disorder: Summary of Findings from the Literature and Clinical Consultation in Ontario Children's Mental Health Ontario Children and Adolescents with
More informationBrief Notes on the Mental Health of Children and Adolescents
Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More informationOverview. Classification, Assessment, and Treatment of Childhood Disorders. Criteria for a Good Classification System
Classification, Assessment, and Treatment of Childhood Disorders Dr. K. A. Korb University of Jos Overview Classification: Identifying major categories or dimensions of behavioral disorders Diagnosis:
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationAlpha-2 Agonists. Antipsychotics
Table 5: Randomized Controlled Trials of Psychotropic Medications in Children and Adolescents with ASD Agent Study Target Symptoms Dose Demographics Significant Side Clonidine Guanfacine Jaselskis et al.,
More informationMental Health 101. Workshop Agreement
Mental Health 101 June 9, 2017 Workshop Agreement Take ownership of your own learning Ask questions Feel free to share safe environment Request an example Be mindful of the different learning styles of
More information2/9/2016. Anxiety. Early Intervention for childhood Mental Health issues. ANXIETY DISORDERS in Children and Adolescents.
ANXIETY DISORDERS in Children and Adolescents. Joy Lauerer DNP PMHCNS BC Discussion Points Anxiety Early Intervention for childhood Mental Health issues Why? Important to long term health outcomes! What
More information5/16/2018. Pediatric Attention Deficit Hyperactivity Disorder: Do you get it?
Pediatric Attention Deficit Hyperactivity Disorder: Do you get it? Mashelle Jansen, DNP, FNP BC Clinical Assistant Professor SUNY Upstate Medical University ADHD is a Commonly diagnosed Childhood Neurodevelopmental
More informationManagement Of Depression And Anxiety
Management Of Depression And Anxiety CME Financial Disclosure Statement I, or an immediate family member including spouse/partner, have at present and/or have had within the last 12 months, or anticipate
More informationDRUGS FOR ADHD: ADOLESCENTS TO ADULTS
DRUGS FOR ADHD: ADOLESCENTS TO ADULTS DISCLOSURE Natasha Rodney-Cail, Pharmacist, Drug Evaluation Unit Has no conflicts of interest Dr. James Chandler, MD, FRCPC Has no conflicts of interest STEVEN Age
More informationAttention deficit hyperactivity disorder (ADHD), Conduct disorder biological treatments
Attention deficit hyperactivity disorder (ADHD), Conduct disorder biological treatments Professor Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Royal
More informationAttention Deficit Hyperactivity Disorder How to manage these disorganized and inattentive children.
Attention Deficit Hyperactivity Disorder How to manage these disorganized and inattentive children. One of the leading authorities on Attention Deficit Hyperactivity Disorder, Russell Barkley, PhD., defines
More informationMental Illness and Disorders Notes
Mental Illness and Disorders Notes Stigma - is a negative and often unfair about mental illness and disorders can cause people with these to not seek help. Deny problem, feel shame and -feel as if they
More informationPOND Family Day Anxiety & Neurodevelopmental Disorders
POND Family Day Anxiety & Neurodevelopmental Disorders Stephanie Ameis, Child & Youth Psychiatrist Centre for Addiction and Mental Health (CAMH) and The Hospital for Sick Children, Assistant Professor,
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder
Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM
Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More informationContemporary Psychiatric-Mental Health Nursing Third Edition. Theories: Anxiety Disorders. Theories: Anxiety Disorders (cont'd) 10/2/2014
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 18 Anxiety Disorders Theories: Anxiety Disorders Biological changes in the brain Neurotransmitters are associated with anxiety. low
More informationOptimistic News and Practical Tools. The Role of Primary Care in Screening and Managing Teen Depression
Optimistic News and Practical Tools The Role of Primary Care in Screening and Managing Teen Depression Meg Durbin, MD Palo Alto Medical Foundation DurbinM@pamf.org Educational Objectives Learn: steps for
More informationForty-Eighth Annual Teaching Conference Pediatrics for the Practitioner -UT Health Science Center San Antonio School of Medicine June 10-12, 2011
Adelaide Robb, MD Associate Professor Psychiatry and Pediatrics Source Advisory Board Disclosure Speaker s Bureau Bristol Myers Squibb Yes Yes Yes Epocrates Research Contract Royalties Yes Stock Janssen
More informationIndex. B Behavioral training for children with ASD, 99 Behavior modification, 5 Brain tumors, 72 Bronfenbrenner s ecological systems Theory, 137
A ABA training behavior modification techniques, 101, 106 UCLA model, 103 Acute Lymphoblastic Leukemia (ALL), 71, 78 Acute pain, 49, 51, 56 Adherence to diabetes regimens, 34 American Cancer Society, 71
More informationSummary ID# Clinical Study Summary: Study B4Z-MC-LYBX
CT Registry ID#7068 Page 1 Summary ID# 7068 Clinical Study Summary: Study B4Z-MC-LYBX A Randomized, Double-Blind Comparison of Hydrochloride and Placebo in Child and Adolescent Outpatients with Attention-
More information5/12/11. Educational Objectives. Goals
Educational Objectives Learn: steps for initial depression screening and management in primary care when to refer to mental health providers tools for providers and patients principles of collaborative
More informationComorbidity and Mimicry in Attention Deficit Hyperactivity Disorder: Implications for Assessment and Treatment 1
Comorbidity and Mimicry in Attention Deficit Hyperactivity Disorder: Implications for Assessment and Treatment 1 James H. Johnson, PhD a, Heather K. Alvarez, PhD b, & Trey A. Johnson, BS a a University
More informationCBT for Hypochondriasis
CBT for Hypochondriasis Ahmad Alsaleh, MD, FRCPC Assistant Professor of Psychiatry College of Medicine, KSAU-HS, Jeddah Agenda Types of Somatoform Disorders Characteristics of Hypochondriasis Basic concepts
More informationMental Health First Aid at a Glance
Mental Health First Aid at a Glance Candice M. Haines, LCPC Program Supervisor Mental Health First Aid Instructor Pilsen Wellness Center chaines@pilsenmh.org Overview Address myths vs facts Warning signs
More informationMedications in Autism: What We Know and Don't Know
Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental
More informationOverview. Part II: Part I: Screening for Depression and Anxiety Risk Assessment Diagnosis of Depressive Disorders
1 Learning Objectives 1. Providers will become familiar with methods of screening for depression and anxiety. 2. Providers will become more comfortable with diagnosis and management of these common pediatric
More informationCommon Adolescent Issues How to Identify and Help
Common Adolescent Issues How to Identify and Help Mark Samways School Counsellor Mark.Samways@dubaicollege.org @DCol_wellbeing Dates of all talks Tuesday 21 st November: Screen Time Tuesday 28 th November:
More informationDisclosure Information
Disclosure Information I have no financial relationships to disclose. I will discuss the off label use of several depression and anxiety medications in pediatric population Pediatric Depression & Anxiety
More information5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development
By Pamela Pepper PMH, CNS, BC DSM-5 Growth and Development The idea that diagnosis is based on subjective criteria and that those criteria should fall neatly into a set of categories is not sustainable,
More informationDepressive disorders in young people: what is going on and what can we do about it? Lecture 1
Depressive disorders in young people: what is going on and what can we do about it? Lecture 1 Professor Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne
More informationAttention Deficit Hyperactivity Disorder The Impact of ADHD on Learning. Miranda Shields, PsyD
Attention Deficit Hyperactivity Disorder The Impact of ADHD on Learning Miranda Shields, PsyD mshields@murrieta.k12.ca.us Definition DSM V Three types 1. Inattentive Type 2. Hyperactive Impulsive Type
More informationLearning, to help them learn Seminar on Learning Disability and ADHD 25th June 2017 Country Inn & Suites, Patto Plaza, Panaji
Learning, to help them learn Seminar on Learning Disability and ADHD 25th June 2017 Country Inn & Suites, Patto Plaza, Panaji Medical Management of ADHD www.antarman.goadoctor.co.in Community Management
More informationManagement Options for Attention Deficit Hyperactivity Disorder. Public Meeting June 1, 2012
Management Options for Attention Deficit Hyperactivity Disorder Public Meeting June 1, 2012 New England CEPAC Goal: To improve the application of evidence to guide practice and policy in New England Method:
More informationAutism Spectrum Disorders & Attention Deficit Disorder in PEDIATRIC PRIMARY CARE. Disclosures
Autism Spectrum Disorders & Attention Deficit Disorder in PEDIATRIC PRIMARY CARE TIPS Conference March 22, 2019 Benjamin L. Handen, PhD, BCBA-D Professor of Psychiatry and Pediatrics Western Psychiatric
More informationADHD and Substance Use Disorders: An Intoxicating Combination
ADHD and Substance Use Disorders: An Intoxicating Combination Timothy E. Wilens, MD Chief, Division of Child & Adolescent Psychiatry Director, Center for Addiction Medicine Massachusetts General Hospital
More informationAnxiety in Youth: Identification, Management, & Referral
Anxiety in Youth: Identification, Management, & Referral Martin E. Franklin, Ph.D. Associate Professor of Psychiatry University of Pennsylvania School of Medicine Prelude to the Talk: Anxiety & Its Disorders
More informationChelsea Murphy MS, NCC. Kennedy Health Systems
Chelsea Murphy MS, NCC Kennedy Health Systems What is ADHD? o Neurobiological Disorder deficit in the neurotransmitters (message senders within the brain) o Dopamine & Norepinephrine are not released as
More informationdepression and anxiety in later life clinical challenges and creative research
2 nd Annual MARC Symposium Critical Themes in Ageing Melbourne, 10 th August 2018 depression and anxiety in later life clinical challenges and creative research Nicola T Lautenschlager, MD, FRANZCP Professor
More informationDifferentiating MDD vs. Bipolar Depression In Youth
Differentiating MDD vs. Bipolar Depression In Youth Mai Uchida, M.D. Staff Physician Clinical and Research Programs in Pediatric Psychopharmacology Massachusetts General Hospital Disclosures Neither I
More informationAnxiety Disorders- OCD. Peter Giacobbe MD FRCPC L. Ravindran MD FRCPC
Anxiety Disorders- OCD Peter Giacobbe MD FRCPC L. Ravindran MD FRCPC Anxiety Disorders - Epidemiology Anxiety disorders are the most common class of mental disorders Estimated lifetime prevalence rates
More information11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE
FACULTY DISCLOSURE INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM KristinDawson, MD Assistant Professor University of Kentucky No commercial conflicts of Interest Salary
More informationMOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS
MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS Shelley Klipp AS91 Spring 2010 TIP 42 Pages 226-231 and 369-379 DSM IV-TR APA 2000 Co-Occurring Substance Abuse and Mental Disorders by John Smith Types
More informationDisclosures. Autism Society of Wisconsin. Case 2. Case 1. Case 3. Case 4 3/29/2018. Medication treatment for people with Autism Spectrum Disorder
Medication treatment for people with Autism Spectrum Disorder Autism Society of Wisconsin April 20, 2018 Richard P. Barthel, M.D. Disclosures In accordance with the ACCME policy on relevant financial disclosure,
More informationPsychopharmacology for Non-MDs - Dr. Suzanne Dieter. March 10, 2017 PEDIATRIC PSYCHOPHARMACOLOGY FOR NON-MDS LEARNING OBJECTIVES
LEARNING OBJECTIVES PEDIATRIC PSYCHOPHARMACOLOGY FOR NON-MDS, MD New York, NY Member, American Academy of Child and Adolescent Psychiatry Understand the role a child psychiatrist can play as part of a
More informationNeuroimaging in Clinical Practice
Neuroimaging in Clinical Practice John Gabrieli Department of Brain and Cognitive Sciences & Martinos Imaging Center at the McGovern Institute for Brain Research, MIT Disclosures Neither I nor my spouse/partner
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners Grand Rounds October 11, 2017 Disclosures One
More informationBrain-based disorders in children, teens, and young adults: When to know there is a problem and what to do
Brain-based disorders in children, teens, and young adults: When to know there is a problem and what to do Timothy A. Fratto, Ph.D. Neuropsychology Associates of Fairfax What is Neuropsychology? The study
More informationEvidence-Based Assessment in School Mental Health
Evidence-Based Assessment in School Mental Health MASBHC May 19, 2015 Jill Bohnenkamp, Ph.D. Elizabeth Connors, Ph.D. Center for School Mental Health, 2015 University of Maryland, Baltimore Objectives
More information8/22/2016. Contemporary Psychiatric-Mental Health Nursing Third Edition. Theories: Anxiety Disorders. Theories: Anxiety Disorders (cont'd)
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 18 Anxiety Disorders Theories: Anxiety Disorders Biological changes in the brain Noradrenergic system is sensitive to norepinephrine;
More informationClinical assessment of ADHD. The size of a clinic s problem. Diagnosis: detecting the disorder. ADHD has several components
Assessment is more than recognition Clinical assessment of ADHD Eric Taylor Department of Child & Adolescent Psychiatry Institute of Psychiatry-Kings College London Detecting the disorder Contextual assessment
More informationPerspective Truth on ADHD & Medications. Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry
Perspective Truth on ADHD & Medications Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry Disclosures National Institute of Health ADHD and Aggression Study Co- Investigator
More informationHow to Manage Anxiety
How to Manage Anxiety Dr Tony Fernando Psychological Medicine University of Auckland Auckland District Health Board www.insomniaspecialist.co.nz www.calm.auckland.ac.nz Topics How to diagnose How to manage
More informationSTRATTERA Generic name: atomoxetine hydrochloride
1 Medication Guide PV 5850 AMP STRATTERA Generic name: atomoxetine hydrochloride Read this information carefully before you start taking STRATTERA (Stra-TAIR-a) to learn about the benefits and risks of
More informationTreatment of Anxiety (without benzos)
Treatment of Anxiety (without benzos) Alison C. Lynch MD MS Clinical Professor Departments of Psychiatry and Family Medicine University of Iowa Health Care None Disclosures Overview/objectives Review common
More informationAnxiety Disorders.
Anxiety Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationDifference between ADHD and Executive Functioning. Dr. Josette Abdalla
Difference between ADHD and Executive Functioning Dr. Josette Abdalla DSM-5 Definition of ADHD The DSM-5 diagnoses 3 types of ADHD: ADHD Predominantly Inattentive type ADHD Predominantly Hyperactive-Impulsive
More informationPsychopharmacology of ADHD. Copyright 2006 Neuroscience Education Institute. All rights reserved.
Psychopharmacology of ADHD Persistence (Predicted Value) Persistence of ADHD Into Adulthood 90 80 70 60 50 40 30 20 10 0 NA 10 15 20 25 30 Age at Follow-Up Syndromatic Persistence Symptomatic Persistence
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More informationAsk The Shrink: ADHD
Ask The Shrink: ADHD Theodore A. Petti, MD Professor of Psychiatry Division of Child and Adolescent Psychiatry Robert Wood Johnson Medical School PPC Hub Psychiatrist Hackensack Meridian Hubs @ Saint Peter'
More informationTITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder.
Brief Summary TITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. SOURCE(S): Practice parameters for the assessment and treatment
More informationSession 3: Help Me, Doc - I ve Got High Anxiety! Learning Objectives
Session 3: Help Me, Doc - I ve Got High Anxiety! Learning Objectives 1. Recognize the distinguishing features of common anxiety disorders seen in primary care. 2. Use screening measures for diagnosis of
More informationMANAGEMENT OF ADHD IN ADULTS
MANAGEMENT OF ADHD IN ADULTS RICHARD MOLDAWSKY, M.D. I Can t Focus on Anything Except Getting My Adderall 1 ASSUMPTIONS FOR TODAY Most of us don t work 2 W s without seeing a person with ADHD You are familiar
More informationPSYCHOLOGICAL PERSPECTIVES PERINATAL ANXIETY DISORDERS
PSYCHOLOGICAL PERSPECTIVES PERINATAL ANXIETY DISORDERS Abbey Kruper, Psy.D. Assistant Professor Department of Obstetrics & Gynecology Medical College of Wisconsin OBJECTIVES 1. Overview of perinatal anxiety
More information